SCHEMBL23770815

SCHEMBL23770815

CNc1cccc(SNc2ccc(C(F)(F)F)c(-c3ccccc3C)n2)n1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 5/20 0.39
CYP2C19 P33261 5/20 0.39
CYP3A4 P08684 4/20 0.39
ALDH1A1 P00352 2/20 0.39
PTPN1 P18031 3/20 0.35
TRPA1 O75762 2/20 0.32
CYP2D6 P10635 3/20 0.32
ALOX15 P16050 2/20 0.32
HSD17B10 Q99714 2/20 0.32
CLK4 Q9HAZ1 1/20 0.32
RECQL P46063 1/20 0.31
TRPM8 Q7Z2W7 1/20 0.31
TRPV1 Q8NER1 1/20 0.31
AR P10275 2/20 0.31
GPBAR1 Q8TDU6 1/20 0.31
KRAS P01116 1/20 0.30
HSD11B1 P28845 1/20 0.30
MAPK1 P28482 1/20 0.30
NUDT1 P36639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23770551 0.88 PTPN1 (0.36) CYP1A2CYP2C19CYP3A4ALDH1A1PTPN1
SCHEMBL23770573 0.85 CCNT1 (0.36) CYP1A2CYP2C19CYP3A4ALDH1A1CYP2D6
SCHEMBL23770706 0.84 SMN1; SMN2 (0.36)
SCHEMBL23770790 0.83 IL1B (0.32)
SCHEMBL23770617 0.82 CYP1A2 (0.39) CYP1A2CYP2C19CYP3A4CYP2D6HSD17B10
SCHEMBL23770399 0.82 PTPN1 (0.35) CYP1A2CYP2C19CYP3A4ALDH1A1PTPN1
SCHEMBL23770433 0.81 PDE10A (0.36) CYP1A2CYP2C19CYP3A4ALDH1A1CYP2D6
SCHEMBL23770664 0.81 NPY5R (0.36) CYP1A2CYP2C19CYP3A4ALDH1A1CYP2D6
SCHEMBL19970087 0.79 CCNT1 (0.35) CYP1A2CYP2C19CYP3A4CYP2D6HSD17B10
SCHEMBL23770405 0.78 PTPN1 (0.31) PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed